Article
Rational Design of the Remdesivir Binding Site in the RNA-dependent RNA Polymerase of SARS-CoV-2: Implications for Potential Resistance
2020-06-29
Abstract excerpt
<h4>ABSTRACT</h4> SARS-CoV-2 is rapidly evolving with the continuous emergence of new mutations. There is no specific antiviral therapy for COVID-19, and the use of Remdesivir for treating COVID-19 will likely continue before clinical trials are completed. Due to the lengthening pandemic and evolving nature of the virus, predicting potential residues prone to mutations is crucial for the management of Remdesivir...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- de1f0009-564b-552d-8e5a-04a8d5d3e83e
- DOI
- 10.1101/2020.06.27.174896
